Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
Publication
, Journal Article
Piccini, JP; Hellkamp, AS; Washam, JB; Becker, RC; Breithardt, G; Berkowitz, SD; Halperin, JL; Hankey, GJ; Hacke, W; Mahaffey, KW; Nessel, CC ...
Published in: Circulation
July 12, 2016
Duke Scholars
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
July 12, 2016
Volume
134
Issue
2
Start / End Page
e7 / e8
Location
United States
Related Subject Headings
- Warfarin
- Stroke
- Rivaroxaban
- Polypharmacy
- Morpholines
- Humans
- Factor Xa Inhibitors
- Cardiovascular System & Hematology
- Atrial Fibrillation
- Anticoagulants
Citation
APA
Chicago
ICMJE
MLA
NLM
Piccini, J. P., Hellkamp, A. S., Washam, J. B., Becker, R. C., Breithardt, G., Berkowitz, S. D., … Patel, M. R. (2016). Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation". Circulation, 134(2), e7–e8. https://doi.org/10.1161/CIRCULATIONAHA.116.022737
Piccini, Jonathan P., Anne S. Hellkamp, Jeffrey B. Washam, Richard C. Becker, Günter Breithardt, Scott D. Berkowitz, Jonathan L. Halperin, et al. “Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".” Circulation 134, no. 2 (July 12, 2016): e7–8. https://doi.org/10.1161/CIRCULATIONAHA.116.022737.
Piccini JP, Hellkamp AS, Washam JB, Becker RC, Breithardt G, Berkowitz SD, et al. Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation". Circulation. 2016 Jul 12;134(2):e7–8.
Piccini, Jonathan P., et al. “Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".” Circulation, vol. 134, no. 2, July 2016, pp. e7–8. Pubmed, doi:10.1161/CIRCULATIONAHA.116.022737.
Piccini JP, Hellkamp AS, Washam JB, Becker RC, Breithardt G, Berkowitz SD, Halperin JL, Hankey GJ, Hacke W, Mahaffey KW, Nessel CC, Singer DE, Fox KAA, Patel MR. Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation". Circulation. 2016 Jul 12;134(2):e7–e8.
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
July 12, 2016
Volume
134
Issue
2
Start / End Page
e7 / e8
Location
United States
Related Subject Headings
- Warfarin
- Stroke
- Rivaroxaban
- Polypharmacy
- Morpholines
- Humans
- Factor Xa Inhibitors
- Cardiovascular System & Hematology
- Atrial Fibrillation
- Anticoagulants